India information Government India

Merck’s Covid pill results raise hopes for developing world

Reading now: 368
www.livemint.com

Licensing Deals The company earlier this year announced that it had signed non-exclusive voluntary licensing agreements for the drug with five generic manufacturers in India in a bid to accelerate availability in more than 100 low- and middle-income countries following approvals or emergency authorization by local regulatory agencies.

Potentially the drug could be very cheap to manufacture and available at a low cost in developing nations, benefiting millions of people, Andrew Hill, a senior research fellow at the University of Liverpool, wrote in an email.  “This could be a major advance in the treatment of Covid-19," he said.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA